Information for the public

Pertuzumab (Perjeta), with trastuzumab and docetaxel, is available on the NHS. It is a possible option for adults who have locally recurrent or metastatic (secondary) breast cancer that:

  • is human epidermal growth factor receptor 2 (HER2)‑positive
  • cannot be removed by surgery and
  • has not been treated with chemotherapy or targeted HER2 therapy before.

Is this treatment right for me?

Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. Read more about making decisions about your care.

Questions to think about

  • How well does it work compared with other treatments?
  • What are the risks or side effects? How likely are they?
  • How will the treatment affect my day-to-day life?
  • What happens if the treatment does not work?
  • What happens if I do not want to have treatment? Are there other treatments available?

Information and support

NHS Choices may be a good place to find out more about breast cancer in women and men.

These organisations can give you advice and support:

You can also get support from your local Healthwatch.

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN: 978-1-4731-2466-0


This page was last updated: 07 March 2018